TechneLite
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- TechneLite
- Generic name
- TECHNETIUM TC99M GENERATOR
- Manufacturer
- Lantheus Medical Imaging, Inc.
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 3ae14c6b-3daf-4dd1-bbdb-e990fe8100e4
- SPL ID
- ffbbca75-06da-47fc-bc12-ceefdf308162
- Version
- 17
- Effective date
- 2024-11-01
- Source export date
- 2026-09-28
- Source partition
- 10
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:09:23
| Harmonized routes |
|---|
| INTRAVENOUS |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | NDA | 017771 | derived:openfda.application_number |
| application number | NDA017771 | openfda.application_number | |
| brand name | TechneLite | openfda.brand_name | |
| generic name | TECHNETIUM TC99M GENERATOR | openfda.generic_name | |
| manufacturer name | Lantheus Medical Imaging, Inc. | openfda.manufacturer_name | |
| ndc | package | 11994-091-13 | openfda.package_ndc |
| ndc | package | 11994-090-01 | openfda.package_ndc |
| ndc | package | 11994-091-11 | openfda.package_ndc |
| ndc | package | 11994-090-92 | openfda.package_ndc |
| ndc | package | 11994-091-04 | openfda.package_ndc |
| ndc | package | 11994-091-05 | openfda.package_ndc |
| ndc | package | 11994-090-73 | openfda.package_ndc |
| ndc | package | 11994-091-73 | openfda.package_ndc |
| ndc | package | 11994-091-01 | openfda.package_ndc |
| ndc | package | 11994-091-06 | openfda.package_ndc |
| ndc | package | 11994-091-10 | openfda.package_ndc |
| ndc | package | 11994-090-36 | openfda.package_ndc |
| ndc | package | 11994-091-03 | openfda.package_ndc |
| ndc | package | 11994-090-03 | openfda.package_ndc |
| ndc | package | 11994-091-36 | openfda.package_ndc |
| ndc | package | 11994-091-92 | openfda.package_ndc |
| ndc | package | 11994-090-09 | openfda.package_ndc |
| ndc | package | 11994-091-12 | openfda.package_ndc |
| ndc | package | 11994-090-12 | openfda.package_ndc |
| ndc | package | 11994-090-11 | openfda.package_ndc |
| ndc | package | 11994-090-06 | openfda.package_ndc |
| ndc | package | 11994-090-04 | openfda.package_ndc |
| ndc | package | 11994-090-05 | openfda.package_ndc |
| ndc | package | 11994-090-10 | openfda.package_ndc |
| ndc | package | 11994-091-07 | openfda.package_ndc |
| ndc | package | 11994-091-09 | openfda.package_ndc |
| ndc | package | 11994-090-13 | openfda.package_ndc |
| ndc | package | 11994-090-07 | openfda.package_ndc |
| ndc | product | 11994-091 | openfda.product_ndc |
| ndc | product | 11994-090 | openfda.product_ndc |
| ndc11 | package | 11994009173 | derived:openfda.package_ndc |
| ndc11 | package | 11994009013 | derived:openfda.package_ndc |
| ndc11 | package | 11994009111 | derived:openfda.package_ndc |
| ndc11 | package | 11994009101 | derived:openfda.package_ndc |
| ndc11 | package | 11994009105 | derived:openfda.package_ndc |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS: Radiation risks associated with the use of Sodium Pertechnetate Tc 99m Injection are greater in children than in adults and, in general, the younger the child, the greater the risk owing to greater absorbed radiation doses and longer life-expectancy. These greater risks should be taken firmly into account in all benefit-risk assessments involving children. Long-term cumulative radiation exposure may be associated with an increased risk of cancer.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS: Allergic reactions including anaphylaxis have been reported infrequently following the administration of Sodium Pertechnetate Tc 99m Injection.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.